Parameter | All population | SHI | LEGA | HAVU | BEMBE–Fuliru | Others | p value |
---|---|---|---|---|---|---|---|
AGE (years) | n: 979 | n: 233 | n: 212 | n: 204 | n: 172 | n: 158 | .62a |
61.12 ± 10.7 | 61.9 ± 11.06 | 61.5 ± 9.8 | 60.5 ± 10.8 | 60.6 ± 11.12 | 60.8 ± 10.4 | ||
Duration of symptoms (years) | n: 979 | n: 233 | n: 212 | n: 203 | n: 172 | n: 157 | .39 |
2 (1, 5) | 2 (1, 5) | 2 (1, 4) | 2 (1, 5) | 2 (1, 5) | |||
IPSS | n: 979 | n: 233 | n: 212 | n: 204 | n: 172 | n: 158 | .043 |
(0–35) | 15 (5, 24) | 19 (7, 27) | 15 (5, 25) | 15 (5, 22) | 14 (8, 20) | 15 (5, 25) | |
QOL score | n: 979 | n: 233 | n: 212 | n: 204 | n: 172 | n: 158 | .0543 |
(1–7) | 5 (2, 6) | 6 (2, 7) | 5 (2, 6) | 5 (2, 6) | 5 (2, 6) | 5 (2, 6) | |
IIEF score | n: 971 | n: 233 | n: 209 | n: 200 | n: 172 | n: 157 | .85 |
(0–25) | 17 (10, 23) | 16 (10, 23) | 16 (10, 25) | 17 (11, 25) | 15 (14, 20) | 18 (11, 23) | |
QMAX (mL/s) | n: 979 | n:233 | n: 212 | n: 204 | n:172 | n:158 | < .001 |
14 (8.9, 19.8) | 14.3 (8.5, 21.6) | 10.7 (7.4, 16.8) | 15.35 (10.05, 22.3) | 14.7 (10.85, 19.8) | 14.79 (9, 20.1) | ||
Micturition duration (Sec) | n:959 | n: 229 | n: 204 | n: 200 | n: 169 | n: 157 | .076 |
17.2 (12.8, 24.5) | 16.6 (12.8, 22.9) | 16.55 (12.5, 23.4) | 16.45 (12.55, 23.7) | 19.1 (14, 27.2) | 18 (13, 24.3) | ||
PVR (mL) | n: 958 | n: 228 | n: 204 | n: 200 | n: 169 | n: 157 | < .001 |
5 (5, 12) | 5 (5, 17) | 5 (5, 5) | 5 (5, 5) | 5 (5, 16) | 5 (5, 15) | ||
Prostate volume (cc) | n: 979 | n: 233 | n: 212 | n: 204 | n: 172 | n: 158 | < .001 |
32 (22, 49) | 33 (24, 46) | 55 (38, 81) | 20 (17, 24) | 30 (23, 42) | 34 (24, 52) |